Patents/Assignees

Ovid Therapeutics Inc.

12 patents in portfolio

US12465597utility2025
Methods of Treating Developmental Disorders with Gaboxadol
0 cites
US12285397utility2025
Use of (s)-3-amino-4-(difluoromethylenyl) Cyclopent-1-ene-1-carboxylic Acid and Related Compounds, (1s,3s)-3-amino-4-(difluoromethylidene) Cyclopentane-1-carboxylic Acid and Vigabatrin in the Treatment of Developmental Disorders
0 cites
US12144801utility2024
Methods and Compositions for Treatment of Epileptic Disorders
0 cites
US12109201utility2024
Methods and Compositions for Treatment of Epileptic Disorders
0 cites
US11918563utility2024
Methods and Compositions for Treatment of Epileptic Disorders
0 cites
US11918551utility2024
Methods of Treating Seizure Disorders and Prader-willi Syndrome
0 cites
US11903930utility2024
Methods and Compositions for Treatment of Epileptic Disorders
0 cites
US11806336utility2023
Methods and Compositions for Treatment of Epileptic Disorders
0 cites
US11771671utility2023
Use of (1s,3s)-3-amino-4-(difluoromethylidene) Cyclopentane-1-carboxylic Acid and (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid in the Treatment of Tinnitus, Acute Sensorineural Hearing Loss, Meniere's Disease, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder and Addiction
0 cites
US11761006utility2023
Use of MIR101 or MIR128 in the Treatment of Seizure Disorders
0 cites
US11690829utility2023
Use of Gaboxadol for the Treatment of Non-24 Hour Sleep-wake Disorder
0 cites
US11660277utility2023
Use of (s)-3-amino-4-(difluoromethylenyl) Cyclopent-1-ene-1-carboxylic Acid and Related Compounds, (1s,3s)-3-amino-4-(difluoromethylidene) Cyclopentane-1-carboxylic Acid and Vigabatrin in the Treatment of Developmental Disorders
0 cites